Advancing Basic Science for Humanity
Salk study is the first to directly examine cells from patients whose depression doesn’t respond to SSRIs.
Columbia-led discovery in mice aids efforts to map the circuitry of the brain’s learning center; stands to inform studies of psychiatric disorders in which this circuitry goes awry.
In rat models, the novel scaffolding mimicked natural anatomy and boosted stem cell-based treatment; the approach is scalable to humans and advances effort toward clinical trials.
Johns Hopkins study sheds light on brain basis of risk-taking behavior
Miniscule wavy hairs called cilia in the cavities of your brain help keep it healthy and function well.
Yale researchers have identified a drinkable cocktail of designer molecules that interferes with a crucial first step of Alzheimer’s.
The most comprehensive genomic analysis of the human brain ever undertaken has revealed new insights into the roots of neuropsychiatric illnesses.
Yale researchers predict how people’s eyes move when viewing natural scenes.
Measuring activity from more neurons in more areas over weeks to months will increase understanding of complex cognitive processes.
Human study suggests lateral orbitofrontal cortex as promising target for therapeutic brain stimulation to treat intractable depression.